Cargando…
Dendritic Cell-Based Vaccine Efficacy: Aiming for Hot Spots
Many approaches for cancer immunotherapy have targeted dendritic cells (DCs), directly or indirectly, for the induction of antitumor immune responses. DC-based vaccines have been developed using a wide variety of ex vivo DC culture conditions, antigen (Ag) source and loading strategies, maturation a...
Autores principales: | Pizzurro, Gabriela Andrea, Barrio, María Marcela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347494/ https://www.ncbi.nlm.nih.gov/pubmed/25784913 http://dx.doi.org/10.3389/fimmu.2015.00091 |
Ejemplares similares
-
Beyond Hot Spots: Biases in Antibody Somatic Hypermutation and Implications for Vaccine Design
por: Schramm, Chaim A., et al.
Publicado: (2018) -
Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy
por: Bartish, Margarita, et al.
Publicado: (2020) -
Dendritic Cells: A Spot on Sialic Acid
por: Crespo, Hélio J., et al.
Publicado: (2013) -
Human Macrophages and Dendritic Cells Can Equally Present MART-1 Antigen to CD8(+) T Cells after Phagocytosis of Gamma-Irradiated Melanoma Cells
por: Barrio, María Marcela, et al.
Publicado: (2012) -
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
por: Repáraz, David, et al.
Publicado: (2022)